Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (3.354.685 €): Europäisches Netzwerk, das Informatik und Genomik von Hilfszellen verbindet Hor 11.08.2015 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Europäisches Netzwerk, das Informatik und Genomik von Hilfszellen verbindet
ENLIGHT-TEN is a European Network Linking Informatics and Genomics of Helper T cells: our mission is to provide cross-disciplinary training in cellular immunology and big data analysis such that we train a new generation of researchers to fully exploit the power of emerging technological platforms. Our network of TEN beneficiaries combines T cell expertise with state-of-the-art technologies such as next generation sequencing (NGS), bioinformatics, multi-colour flow cytometry, preclinical models and tailored genome editing. Trainees will acquire a comprehensive knowledge in T cell immunology and the capacity to generate and interrogate big data sets as well as expertise in identifying novel biomarkers and developing therapeutic concepts. As such the training programme will provide an ideal stepping-stone for creative and innovative early stage researchers (ESRs) to enter and strengthen Europe’s academia as well as pharmaceutical and bioinformatics companies. The research focus of the network lies in the identification of extrinsic and intrinsic factors that control development, differentiation and plasticity of helper T cell subsets with particular emphasis on how T cell differentiation impacts on human diseases. The generation of large data sets is an emerging and challenging field, and there is high demand in both the academic sector as well as pharmaceutical companies for researchers to be able to analyse, integrate and exploit this rich source of information. ENLIGHT-TEN will combine the individual strengths of innovative laboratories and enterprises from complementary disciplines to provide unique interdisciplinary training for 13 ESRs, placing them at the forefront of this emerging field. Trainees will be empowered to perform cutting-edge analysis of the steadily increasing number of different T cell subsets, which play highly diverse and critical roles in the development of autoimmune diseases, making them a key target for pharmaceutical companies.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Abcam plc | ? |
| Bayer AG | 145.376 € |
| Bayer Pharma AG | 103.840 € |
| European Molecular Biology Laboratory | 0,00 € |
| Genome Research Ltd. LBG | 273.288 € |
| Helmholtz-Zentrum FUR Infektionsforschung GmbH | 498.433 € |
| Institut National de la Sante et de la Recherche Medicale | 262.876 € |
| Instituto de Medicina Molecular Joao Lobo Antunes | 476.713 € |
| Medizinische Universitaet Wien | 255.934 € |
| Qiagen Aarhus AS | 249.216 € |
| The Babraham Institute | 546.576 € |
| Turun Yliopisto | 269.145 € |
| University College London | 273.288 € |
Quelle: https://cordis.europa.eu/project/id/675395
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Abcam Ltd., Cambridge, Großbritannien.